Externautics S.p.a.

Matteo Parri

Renata Grifantini

Piero Pileri

Alberto Grandi

Susanna Campagnoli

Andrea Pierleoni

Renzo Nogarotto

Jin Boquan

Newly identified proteins as markers for the detection of colon, ovary, kidney, esophagus and prostate tumors, or as therapeutic targets for their treatment; affinity ligands and particularly antibodies capable of selectively interacting with the tumor markers and methods for tumor diagnosis and therapy using such antibodies.

Tumor marker, monoclonal antibodies and methods of use thereof

Newly identified proteins as markers for the detection of ovary tumors, or as therapeutic targets for treatment thereof; affinity ligands capable of selectively interacting with the newly identified markers, methods for tumor diagnosis and therapy using the same.

Ovary tumor markers and methods of use thereof

Newly identified proteins as markers for the detection of prostate tumors, or as targets for their therapeutic treatment, affinity ligands capable of selectively interacting with said markers as well as methods for tumor diagnosis and therapy using the same.

Prostate tumor markers and methods of use thereof

Growing community of inventors

Siena, Italy

Matteo Parri